Global Helicobacter Pylori Diagnostics Market Size, Status and Forecast 2019-2025

Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations.
One of the key drivers witnessed in the market is the growing cost-effectiveness of diagnosis and personalized antibiotic therapy. H. pylori bacteria causes ulcer. H. pylori infection requires antibiotic therapy that includes 10-14 days treatment regimen. This treatment regimen comprises of one or two antibiotics such as amoxicillin, tetracycline, metronidazole, or clarithromycin in combination with ranitidine bismuth citrate, bismuth subsalicylate, and a proton pump inhibitor (PPI). Ulcer-related symptoms such as abdominal pain and nausea and inflammation of gastric mucosa can be cured using PPIs or H2 blockers in combination with antibiotics. The cost-effectiveness of antibiotics and the lesser duration of treatment boosts the adoption of antibiotic regimen by healthcare professionals. This in turn, will drive the demand for pre- and post-monitoring tests.

In terms of geography, the Europe accounted for the majority market shares during 2017 and this mainly accounted to the growing prevalence of peptic ulcer disease and gastritis. The increasing patient pool looking for the early detection of symptoms and treatment is boosting the demand for helicobacter pylori diagnostics in the region. Owing to the continuous efforts of vendors to develop a vaccination for H. pylori infection and the introduction of improved diagnostic techniques, the market will continue to witness considerable growth in this region during the next four years as well.

The helicobacter pylori diagnostics market is characterized by the presence of major vendors and is highly competitive. These vendors compete against each other based on factors including pricing, product differentiation, and advancements in technology. Vendors are highly focusing on expanding their product portfolio and increasing investments in acquiring other players, which will help them increase their revenue shares. Additionally, they are also focusing on the development of vaccines and enhancing their presence in the regional and untapped markets.

Hospitals and clinics reduce the overall disease burden and promote health by offering immunoassays and molecular diagnostic techniques. These techniques enable the early diagnosis of infectious and lethal diseases. The patient pool suffering from infectious diseases such as bacterial diseases (enteric bacteria), cancer, and other life-threatening diseases highly rely on hospitals since they have tie-ups with research and developmental centers and research institutes.

In 2018, the global Helicobacter Pylori Diagnostics market size was 480 million US$ and it is expected to reach 840 million US$ by the end of 2025, with a CAGR of 7.3% during 2019-2025.

This report focuses on the global Helicobacter Pylori Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Helicobacter Pylori Diagnostics development in United States, Europe and China.

The key players covered in this study
Sekisui Diagnostics
F. Hoffmann-La Roche
Medline Industries
Meridian Bioscience
Bio-Rad Laboratories
Thermo Fisher Scientific
Alpha Laboratories
EKF Diagnostics
Halyard Health, Inc
Cardinal Health
Beckman Coulter Inc
Agilent Technologies
Coris BioConcept

Market segment by Type, the product can be split into
Invasive Techniques
Non-invasive Techniques

Market segment by Application, split into
Hospitals and Clinics
Diagnostic Laboratories

Market segment by Regions/Countries, this report covers
United States
Southeast Asia
Central & South America

The study objectives of this report are:
To analyze global Helicobacter Pylori Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Helicobacter Pylori Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Helicobacter Pylori Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports